Inhibition of toxicity in the beta-amyloid peptide fragment beta -(25-35) using N-methylated derivatives: a general strategy to prevent amyloid formation.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Journal of Biological Chemistry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  PMID 10825171
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Two-dimensional structure of beta-amyloid(10-35) fibrils.

  2000cited by this paper
• Reversion of prion protein conformational changes by synthetic beta-sheet breaker peptides.

  2000cited by this paper
• Translating cell biology into therapeutic advances in Alzheimer's disease

  1999cited by this paper
• Modified-peptide inhibitors of amyloid beta-peptide polymerization.

  1999cited by this paper
• Aberrant Protein Deposition and Neurological Disease*

  1999cited by this paper
• Protein misfolding, evolution and disease.

  1999cited by this paper
• Assembly of A beta amyloid protofibrils: an in vitro model for a possible early event in Alzheimer's disease.

  1999cited by this paper
• Conformational changes and disease--serpins, prions and Alzheimer's.

  1998cited by this paper
• Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins.

  1998cited by this paper
• Specific Inhibition of in Vitro Formation of Protease-resistant Prion Protein by Synthetic Peptides*

  1998cited by this paper
• β-sheet breaker peptides inhibit fibrillogenesis in a rat brain model of amyloidosis: Implications for Alzheimer's therapy

  1998cited by this paper
• Controlling amyloid beta-peptide fibril formation with protease-stable ligands.

  1997cited by this paper
• Inhibition of amyloid formation: a strategy to delay the onset of Alzheimer's disease.

  1997cited by this paper
• The presenilin 2 mutation (N141I) linked to familial Alzheimer disease (Volga German families) increases the secretion of amyloid beta protein ending at the 42nd (or 43rd) residue.

  1997cited by this paper
• All-D-Enantiomers of β-Amyloid Exhibit Similar Biological Properties to All-L-β-Amyloids*

  1997cited by this paper
• Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta.

  1996cited by this paper
• A Strategy for Designing Inhibitors of β-Amyloid Toxicity*

  1996cited by this paper
• Amyloid β-Protein and the Genetics of Alzheimer's Disease*

  1996cited by this paper
• Arrest of -Amyloid Fibril Formation by a Pentapeptide Ligand (*)

  1996cited by this paper
• A beta A4 amyloid precursor protein gene and Alzheimer's disease.

  1996cited by this paper
• Two-hybrid system as a model to study the interaction of beta-amyloid peptide monomers.

  1996cited by this paper
• Inhibition of Alzheimer's amyloidosis by peptides that prevent beta-sheet conformation.

  1996cited by this paper
• The toxicity in vitro of beta-amyloid protein.

  1995cited by this paper
• Familial Alzheimer's disease in kindreds with missense mutations in a gene on chromosome 1 related to the Alzheimer's disease type 3 gene

  1995cited by this paper
• Prolines and amyloidogenicity in fragments of the Alzheimer's peptide beta/A4.

  1995cited by this paper
• Cloning of a gene bearing missense mutations in early-onset familial Alzheimer's disease

  1995cited by this paper
• Untangling the pathophysiochemistry of beta-amyloid.

  1995cited by this paper
• Structure-activity analyses of beta-amyloid peptides: contributions of the beta 25-35 region to aggregation and neurotoxicity.

  1995cited by this paper
• The intracellular component of cellular 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) reduction is specifically inhibited by beta-amyloid peptides.

  1995cited by this paper
• Inhibition of PC12 cell redox activity is a specific, early indicator of the mechanism of beta-amyloid-mediated cell death.

  1994cited by this paper
• Reversible random coil-beta-sheet transition of the Alzheimer beta-amyloid fragment (25-35).

  1994cited by this paper
• Role of the beta-amyloid precursor protein in Alzheimer's disease.

  1994cited by this paper
• Normal and abnormal biology of the beta-amyloid precursor protein.

  1994cited by this paper
• Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

  1994cited by this paper
• Thioflavine T interaction with synthetic Alzheimer's disease β‐amyloid peptides: Detection of amyloid aggregation in solution

  1993cited by this paper
• Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state

  1993cited by this paper
• Vitamin E protects nerve cells from amyloid beta protein toxicity.

  1992cited by this paper
• Quantitative evaluation of congo red binding to amyloid-like proteins with a beta-pleated sheet conformation.

  1989cited by this paper
• Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill.

  1989cited by this paper
• X-ray diffraction from intraneuronal paired helical filaments and extraneuronal amyloid fibers in Alzheimer disease indicates cross-beta conformation.

  1986cited by this paper
• Conformational energy studies on N‐methylated analogs of thyrotropin releasing hormone, enkephalin, and luteinizing hormone‐releasing hormone

  1980cited by this paper

• How short peptides disassemble tau fibrils in Alzheimer’s disease

  2025cites this paper
• A phage displaying an Aβ-interacting peptide mitigates neurotoxicity and prevents Aβ-driven gene expression changes

  2025cites this paper
• Dual-Functional Synthetic Linear and Cyclic Peptides with Anti-Amyloid and Antimicrobial Activities for Alzheimer's disease.

  2025cites this paper
• Inhibiting Alzheimer's Disease by Targeting Aggregation of Beta-Amyloid

  2025cites this paper
• Human serum albumin as a potential drug delivery system for N-methylated hot spot insulin analogs inhibiting hormone aggregation.

  2024cites this paper
• Understanding β-strand mediated protein–protein interactions: tuning binding behaviour of intrinsically disordered sequences by backbone modification

  2024cites this paper
• Beyond N-Alkylation: Synthesis, Structure, and Function of N-Amino Peptides.

  2024cites this paper
• How short peptides can disassemble ultra-stable tau fibrils extracted from Alzheimer’s disease brain by a strain-relief mechanism

  2024cites this paper
• Amyloid engineering - how terminal capping modifies morphology and secondary structure of supramolecular peptide aggregates.

  2024cites this paper
• α-Methylation Enables the X-ray Crystallographic Observation of Oligomeric Assemblies Formed by a β-Hairpin Peptide Derived from Aβ

  2024cites this paper
• Effect of the aggregation state of amyloid-beta (25-35) on the brain oxidative stress in vivo

  2024cites this paper
• Peptide-based approaches to directly target alpha-synuclein in Parkinson’s disease

  2023cites this paper
• Backbone N-methylation of peptides: Advances in synthesis and applications in pharmaceutical drug development.

  2023cites this paper
• Nα‐Methylation of arginine: Implications for cell‐penetrating peptides

  2022cites this paper
• Genistein attenuates memory impairment in Alzheimer's disease via ERS-mediated apoptotic pathway in vivo and in vitro.

  2022cites this paper
• Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly

  2022cites this paper
• Simultaneous Inhibitory Effects of All-Trans Astaxanthin on Acetylcholinesterase and Oxidative Stress

  2022cites this paper
• Macrocyclic Peptides Derived from Familial Alzheimer's Disease Mutants Show Charge-Dependent Oligomeric Assembly and Toxicity.

  2022cites this paper
• Sustainable Production of N-methylphenylalanine by Reductive Methylamination of Phenylpyruvate Using Engineered Corynebacterium glutamicum

  2021cites this paper
• N-Amination Converts Amyloidogenic Tau Peptides into Soluble Antagonists of Cellular Seeding.

  2021cites this paper
• Peptide backbone modifications of amyloid β (1–40) impact fibrillation behavior and neuronal toxicity

  2021cites this paper
• Invasive and non-invasive therapies for Alzheimer’s disease and other amyloidosis

  2020cites this paper
• Neural stem cell-conditioned medium ameliorates Aβ25–35-induced damage in SH-SY5Y cells by protecting mitochondrial function

  2020cites this paper
• Interpenetrating Cubes in the X-Ray Crystallographic Structure of a Peptide Derived from Medin19-36.

  2020cites this paper
• Memory-Enhancing Effects of Mangosteen Pericarp Water Extract through Antioxidative Neuroprotection and Anti-Apoptotic Action

  2020cites this paper
• Paeoniflorin ameliorates Aβ-stimulated neuroinflammation via regulation of NF-κB signaling pathway and Aβ degradation in C6 glial cells

  2020cites this paper
• Context dependent cytokine secretion by stem cell derived microglia in vitro

  2020cites this paper
• The role of oxidized Gly25, Gly29 and Gly33 residues on the interactions of Aβ1-42 with lipid membranes.

  2020cites this paper
• N‐Methylated Analogs of hIAPP Fragments 18–22, 23–27, 33–37 Inhibit Aggregation of the Amyloidogenic Core of the Hormone

  2020cites this paper
• Amyloid beta25‐35 impairs docosahexaenoic acid efflux by down‐regulating fatty acid transport protein 1 (FATP1/SLC27A1) protein expression in human brain capillary endothelial cells

  2019cites this paper
• Molecular Dynamics Simulations of Small-Molecule Inhibitors of β-Amyloid Aggregation

  2019cites this paper
• Fundamentals of cross-seeding of amyloid proteins: an introduction.

  2019cites this paper
• AGGREGATION STUDIES, DESIGN AND SYNTHESIS OF AMYLOID AGGREGATION INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE

  2019cites this paper
• Methyl B12 protects PC12 cells against cytotoxicity induced by Aβ25−35

  2019cites this paper
• Peptide‐Based Molecular Strategies To Interfere with Protein Misfolding, Aggregation, and Cell Degeneration

  2019cites this paper
• Homotrimerization Approach in the Design of Thrombospondin-1 Mimetic Peptides with Improved Potency in Triggering Regulated Cell Death of Cancer Cells.

  2019cites this paper
• Functionalized chitosan-modified defect-related luminescent mesoporous silica nanoparticles as new inhibitors for hIAPP aggregation

  2019cites this paper
• Oroxylum indicum (L.) extract protects human neuroblastoma SH‑SY5Y cells against β‑amyloid‑induced cell injury.

  2019cites this paper
• Insulin Hot-Spot Analogs Formed with N-Methylated Amino Acid Residues Inhibit Aggregation of Native Hormone

  2019cites this paper
• Targeting of Disordered Proteins by Small Molecules in Neurodegenerative Diseases.

  2018cites this paper
• Fine-tuning the physicochemical properties of peptide-based blood-brain barrier shuttles.

  2018cites this paper
• Effects of Acetylcholine on β-Amyloid-Induced cPLA2 Activation in the TB Neuroectodermal Cell Line: Implications for the Pathogenesis of Alzheimer’s Disease

  2018cites this paper
• Neuroprotective effects of cordycepin inhibit A&bgr;‐induced apoptosis in hippocampal neurons

  2018cites this paper
• An intranasally delivered peptide drug ameliorates cognitive decline in Alzheimer transgenic mice

  2017cites this paper
• Inhibition of amyloid oligomerization into different supramolecular architectures by small molecules: mechanistic insights and design rules.

  2017cites this paper
• Backbone Engineering within a Latent β-Hairpin Structure to Design Inhibitors of Polyglutamine Amyloid Formation.

  2017cites this paper
• A review on protein misfolding, aggregation and strategies to prevent related ailments.

  2017cites this paper
• Development of proteolytically stable N-methylated peptide inhibitors of aggregation of the amylin peptide implicated in type 2 diabetes

  2017cites this paper
• Molecular dynamics simulation on the inhibition mechanism of peptide‐based inhibitor of islet amyloid polypeptide (IAPP) to islet amyloid polypeptide (IAPP22–28) oligomers

  2017cites this paper
• Rationally Designed Peptides and Peptidomimetics as Inhibitors of Amyloid-β (Aβ) Aggregation: Potential Therapeutics of Alzheimer's Disease.

  2017cites this paper
• Visible‐Light Microscopic Discovery of Up to 150 μm Long Helical Amyloid Fibrils Built of the Dodecapeptide H‐(Val‐Ala‐Leu)4‐OH and of Decapeptides Derived from Insulin

  2016cites this paper
• Modulators of Amyloid β-Protein (Aβ) Self-Assembly

  2016cites this paper
• Effects of N‐Methylated Amyloid‐β30–40 Peptides on the Fibrillation of Amyloid‐β1–40

  2016cites this paper
• Intranasal Administration of a Polyethylenimine-Conjugated Scavenger Peptide Reduces Amyloid-β Accumulation in a Mouse Model of Alzheimer’s Disease

  2016cites this paper
• Clues for divergent, polymorphic amyloidogenesis through dissection of amyloid forming steps of bovine carbonic anhydrase and its critical amyloid forming stretch.

  2016cites this paper
• Olfactory Ensheathing Cell-Conditioned Medium Reverts Aβ25–35-Induced Oxidative Damage in SH-SY5Y Cells by Modulating the Mitochondria-Mediated Apoptotic Pathway

  2016cites this paper
• Hydrogen Bond Networks and Hydrophobic Effects in the Amyloid β30–35 Chain in Water: A Molecular Dynamics Study

  2016cites this paper
• Study of a Bifunctional Aβ Aggregation Inhibitor with the Abilities of Antiamyloid-β and Copper Chelation.

  2016cites this paper
• Peptide backbone modification in the bend region of amyloid‐β inhibits fibrillogenesis but not oligomer formation

  2016cites this paper
• Protein aggregation and neurodegenerative diseases: From theory to therapy.

  2016cites this paper
• Hydrophobic tail length plays a pivotal role in amyloid beta (25–35) fibril–surfactant interactions

  2016cites this paper
• SOD3 Ameliorates Aβ25–35-Induced Oxidative Damage in SH-SY5Y Cells by Inhibiting the Mitochondrial Pathway

  2016cites this paper
• Triptolide attenuated injury via inhibiting oxidative stress in Amyloid-Beta25-35-treated differentiated PC12 cells.

  2016cites this paper
• Modulation of Amyloid β-Protein (Aβ) Assembly by Homologous C-Terminal Fragments as a Strategy for Inhibiting Aβ Toxicity.

  2016cites this paper
• Specific pools of endogenous peptides are present in gametophore, protonema, and protoplast cells of the moss Physcomitrella patens

  2015cites this paper
• Fluorescent Filter-Trap Assay for Amyloid Fibril Formation Kinetics in Complex Solutions

  2015cites this paper
• The Helicase Activity of Hyperthermophilic Archaeal MCM is Enhanced at High Temperatures by Lysine Methylation

  2015cites this paper
• The discovery of a novel series of amyloid-β antiaggregants based on the structure of 3-hydroxyanthranilic acid: a detailed analysis of the mechanism of action underpinning antiaggregant activity

  2015cites this paper
• Aβ42-oligomer Interacting Peptide (AIP) neutralizes toxic amyloid-β42 species and protects synaptic structure and function

  2015cites this paper
• The neuritogenic and neuroprotective potential of senegenin against Aβ-induced neurotoxicity in PC 12 cells

  2015cites this paper
• β-sheet interfering molecules acting against β-amyloid aggregation and fibrillogenesis.

  2015cites this paper
• On the lag phase in amyloid fibril formation

  2015cites this paper
• Critical analysis of Alzheimer's amyloid-beta toxicity to mitochondria.

  2015cites this paper
• Intracellular Screening of a Peptide Library to Derive a Potent Peptide Inhibitor of α-Synuclein Aggregation*

  2015cites this paper
• The effect of N-methylation of amino acids (Ac-X-OMe) on solubility and conformation: a DFT study.

  2015cites this paper
• Amyloid cascade hypothesis: Pathogenesis and therapeutic strategies in Alzheimer's disease.

  2015cites this paper
• In Vitro Neuroprotective Activities of Compounds from Angelica shikokiana Makino

  2015cites this paper
• Capping of Aβ42 Oligomers by Small Molecule Inhibitors

  2014cites this paper
• Synthesis of long-chain fatty acid derivatives as a novel anti-Alzheimer's agent.

  2014cites this paper
• Intracellular selection of peptide inhibitors that target disulphide‐bridged Aβ42 oligomers

  2014cites this paper
• Amyloid aggregation inhibitory mechanism of arginine-rich D-peptides.

  2014cites this paper
• Retro-inversal of intracellular selected β-amyloid-interacting peptides: implications for a novel Alzheimer's disease treatment.

  2014cites this paper
• Molecular understanding of a potential functional link between antimicrobial and amyloid peptides.

  2014cites this paper
• Charge dependent retardation of amyloid β aggregation by hydrophilic proteins.

  2014cites this paper
• Conformational study of N-methylated alanine peptides and design of Abeta inhibitor.

  2014cites this paper
• Rational design and identification of a non-peptidic aggregation inhibitor of amyloid-β based on a pharmacophore motif obtained from cyclo[-Lys-Leu-Val-Phe-Phe-].

  2014cites this paper
• Mulberry Extracts Alleviate Aβ 25–35-Induced Injury and Change the Gene Expression Profile in PC12 Cells

  2014cites this paper
• Neuroprotection against Aβ25-35-induced apoptosis by Salvia miltiorrhiza extract in SH-SY5Y cells.

  2014cites this paper
• Interaction of Aβ(25–35) fibrillation products with mitochondria: Effect of small‐molecule natural products

  2014cites this paper
• Antioxidant and antiapoptotic effects of 1,1'-(biphenyl-4,4'-diyl)-bis(3-(dimethylamino)-propan-1-one) on protecting PC12 cells from Aβ-induced injury.

  2014cites this paper
• Protein fibrillation and nanoparticle interactions: opportunities and challenges.

  2013cites this paper
• Peptide-Lipid Interactions: Experiments and Applications

  2013cites this paper
• Combining intracellular selection with protein-fragment complementation to derive Aβ interacting peptides

  2013cites this paper
• Selectively N-methylated soluble IAPP mimics as potent IAPP receptor agonists and nanomolar inhibitors of cytotoxic self-assembly of both IAPP and Aβ40.

  2013cites this paper
• Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases.

  2013cites this paper
• Expression and characterisation of cardiovascular amyloid proteins

  2013cites this paper
• A new class of aggregation inhibitor of amyloid-β peptide based on an O-acyl isopeptide.

  2013cites this paper
• Effect of the amyloid β hairpin's structure on the handedness of helices formed by its aggregates

  2013cites this paper
• A multifunctional peptide rescues memory deficits in Alzheimer's disease transgenic mice by inhibiting Aβ42-induced cytotoxicity and increasing microglial phagocytosis.

  2012cites this paper
• Chemical strategies for controlling protein folding and elucidating the molecular mechanisms of amyloid formation and toxicity.

  2012cites this paper